Financhill
Buy
58

DSDVY Quote, Financials, Valuation and Earnings

Last price:
$105.77
Seasonality move :
2.03%
Day range:
$103.98 - $105.78
52-week range:
$70.19 - $115.75
Dividend yield:
0.48%
P/E ratio:
28.25x
P/S ratio:
1.91x
P/B ratio:
4.59x
Volume:
42.6K
Avg. volume:
83.5K
1-year change:
24.49%
Market cap:
$49.5B
Revenue:
$21.9B
EPS (TTM):
$3.74
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $14.2B $17.8B $29B $33.4B $21.9B
Revenue Growth (YoY) 13.39% 25.1% 63.31% 15.17% -34.47%
 
Cost of Revenues $11.2B $13.4B $23B $26B $15.5B
Gross Profit $3B $4.4B $6B $7.4B $6.4B
Gross Profit Margin 21.24% 24.61% 20.63% 22.13% 29.06%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $469.8M $504.2M -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2B $2.9B $3.4B $3.8B $3.8B
Operating Income $997.7M $1.5B $2.6B $3.6B $2.6B
 
Net Interest Expenses $100.8M $104.2M $126M $162.9M $156.8M
EBT. Incl. Unusual Items $749.1M $862.2M $2.4B $3.3B $2.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $193.4M $209.8M $580.8M $786.8M $592.8M
Net Income to Company $1.5B $2.1B $3.2B $4.3B $3.3B
 
Minority Interest in Earnings -$899.7K -$1.2M -$7.8M -$14.6M -$13.4M
Net Income to Common Excl Extra Items $554.8M $651.2M $1.8B $2.5B $1.8B
 
Basic EPS (Cont. Ops) $1.40 $1.43 $3.92 $5.48 $4.19
Diluted EPS (Cont. Ops) $1.38 $1.41 $3.83 $5.40 $4.15
Weighted Average Basic Share $396.5M $454.5M $455M $454.6M $427M
Weighted Average Diluted Share $402.8M $463.2M $465.3M $460.9M $431M
 
EBITDA $869.2M $1.6B $3.2B $4.2B $3.4B
EBIT $869.2M $1B $2.5B $3.5B $2.6B
 
Revenue (Reported) $14.2B $17.8B $29B $33.4B $21.9B
Operating Income (Reported) $997.7M $1.5B $2.6B $3.6B $2.6B
Operating Income (Adjusted) $869.2M $1B $2.5B $3.5B $2.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $4.4B $7.9B $8.2B $5.2B $6.5B
Revenue Growth (YoY) 20.95% 77.83% 4.35% -36.63% 25.08%
 
Cost of Revenues $3.3B $6.3B $6.4B $3.6B $4.9B
Gross Profit $1.1B $1.6B $1.8B $1.6B $1.6B
Gross Profit Margin 25.79% 19.82% 22.36% 29.93% 25.13%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $130.5M -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $711.2M $848.3M $952M $913.2M $981.5M
Operating Income $428.1M $709M $880.8M $642M $651.4M
 
Net Interest Expenses $75.1M $26.2M $14.4M $91.9M $75.9M
EBT. Incl. Unusual Items $281.8M $658.4M $804.7M $550.1M $557.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $71.8M $157.3M $205.5M $140M $137.9M
Net Income to Company $642.3M $844.4M $925.1M $834.5M $894M
 
Minority Interest in Earnings $628.4K -$3.6M -$4.9M -$4.4M -$3.2M
Net Income to Common Excl Extra Items $210.7M $497.5M $594.3M $405.7M $416M
 
Basic EPS (Cont. Ops) $0.46 $1.09 $1.31 $0.96 $1.00
Diluted EPS (Cont. Ops) $0.46 $1.06 $1.30 $0.95 $1.00
Weighted Average Basic Share $454.6M $458.1M $452.6M $424.1M $415.1M
Weighted Average Diluted Share $462.4M $468.4M $457.3M $427.4M $415.1M
 
EBITDA $521.2M $869M $1B $839.5M $853.7M
EBIT $366M $703.4M $830.3M $645.6M $643M
 
Revenue (Reported) $4.4B $7.9B $8.2B $5.2B $6.5B
Operating Income (Reported) $428.1M $709M $880.8M $642M $651.4M
Operating Income (Adjusted) $366M $703.4M $830.3M $645.6M $643M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $17.2B $24.5B $35.8B $23.7B $23.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $13.2B $19.8B $28.2B $17.2B $17.1B
Gross Profit $3.9B $4.7B $7.6B $6.5B $6.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $526.9M -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.6B $2.5B $3.9B $3.8B $3.9B
Operating Income $1.3B $2.2B $3.7B $2.7B $2.3B
 
Net Interest Expenses $222.1M -- $192.1M $194.1M $211.9M
EBT. Incl. Unusual Items $738M $1.9B $3.3B $2.5B $2.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $207.8M $449.6M $820.6M $602.8M $508M
Net Income to Company $2B $2.7B $4.3B $3.6B $3.2B
 
Minority Interest in Earnings -$2M -$4.6M -$15.4M -$12.2M -$11.5M
Net Income to Common Excl Extra Items $528.1M $1.5B $2.5B $1.9B $1.6B
 
Basic EPS (Cont. Ops) $1.11 $3.28 $5.34 $4.37 $3.77
Diluted EPS (Cont. Ops) $1.09 $3.20 $5.26 $4.32 $3.74
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $1.2B $2.4B $4.2B $3.5B $3.2B
EBIT $1B $2B $3.5B $2.7B $2.3B
 
Revenue (Reported) $17.2B $24.5B $35.8B $23.7B $23.3B
Operating Income (Reported) $1.3B $2.2B $3.7B $2.7B $2.3B
Operating Income (Adjusted) $1B $2B $3.5B $2.7B $2.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $12.7B $19.4B $26.4B $16.6B $18B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $10.7B $15.9B $20.6B $11.8B $13.3B
Gross Profit $2B $3.5B $5.8B $4.9B $4.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $375.9M $270.2M -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $956.6M $1.8B $2.9B $2.9B $2.9B
Operating Income $1B $1.8B $2.9B $2B $1.8B
 
Net Interest Expenses $196M $70.6M $137.9M $166.9M $221.6M
EBT. Incl. Unusual Items $626.5M $1.7B $2.6B $1.8B $1.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $162.3M $401.7M $643.7M $459.1M $374.2M
Net Income to Company $1.6B $2.2B $3.3B $2.6B $2.4B
 
Minority Interest in Earnings -$552.9K -$4M -$11.7M -$9.3M -$7.4M
Net Income to Common Excl Extra Items $463.6M $1.3B $2B $1.4B $1.2B
 
Basic EPS (Cont. Ops) $1.02 $2.85 $4.29 $3.19 $2.76
Diluted EPS (Cont. Ops) $1.00 $2.79 $4.23 $3.16 $2.76
Weighted Average Basic Share $1.3B $1.4B $1.4B $1.3B $1.3B
Weighted Average Diluted Share $1.4B $1.4B $1.4B $1.3B $1.3B
 
EBITDA $1B $2.1B $3.3B $2.6B $2.4B
EBIT $854.6M $1.8B $2.8B $2B $1.8B
 
Revenue (Reported) $12.7B $19.4B $26.4B $16.6B $18B
Operating Income (Reported) $1B $1.8B $2.9B $2B $1.8B
Operating Income (Adjusted) $854.6M $1.8B $2.8B $2B $1.8B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $306.3M $671.1M $1.3B $1.2B $673.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.7B $3.1B $5.5B $4.7B $3.3B
Inventory $198.5M $235.7M $43.2M $271.9M $640.5M
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $4.2B $5B $9B $7.8B $6.3B
 
Property Plant And Equipment $2.2B $2.3B $3B $3B $3.2B
Long-Term Investments -- -- -- -- --
Goodwill $7.5B $7.8B $11.4B $11B $11.3B
Other Intangibles $260.6M $196.5M $243.3M $198.8M $197.8M
Other Long-Term Assets -- -- -- -- --
Total Assets $14.6B $15.9B $24.6B $22.9B $21.8B
 
Accounts Payable $1.5B $1.6B $2.6B $2.2B $1.9B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $507.5M $471.1M $523.7M $514.8M $565.4M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $4.4B $4.8B $8.1B $6.7B $5.7B
 
Long-Term Debt $969.1M $1.3B $2.6B $3.1B $3B
Capital Leases -- -- -- -- --
Total Liabilities $7.2B $8.1B $13.3B $12.6B $11.6B
 
Common Stock $35.2M $38M $36.5M $31.5M $32.5M
Other Common Equity Adj -- -- -- -- --
Common Equity $7.4B $7.8B $11.3B $10.3B $10.2B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -$16.6M -$14.5M $26.6M $32M $39M
Total Equity $7.4B $7.8B $11.3B $10.3B $10.2B
 
Total Liabilities and Equity $14.6B $15.9B $24.6B $22.9B $21.8B
Cash and Short Terms $306.3M $671.1M $1.3B $1.2B $673.2M
Total Debt $1.2B $1.5B $3.3B $3.2B $3.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $458.7M $1.3B $1.7B $1.2B $1.3B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $3B $5.3B $5.2B $3.1B $4.1B
Inventory $245.5M $418.6M $158.3M $587.2M $580.4M
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $4.6B $8.8B $8.8B $6.4B $7.6B
 
Property Plant And Equipment $2.1B $3B $2.7B $3.2B $3.7B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $15B $24.4B $23B $21.3B $23.7B
 
Accounts Payable $1.5B $2.5B $2.2B $1.8B $2.2B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $456M $499.2M $467.4M $529.1M $624.1M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $4.3B $7.4B $7.3B $5.7B $6B
 
Long-Term Debt $1.3B $2.8B $2.8B $2.8B $3.6B
Capital Leases -- -- -- -- --
Total Liabilities $7.4B $12.8B $12.4B $11.4B $12.9B
 
Common Stock $36.3M $37.4M $30.9M $31M $32.1M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -$15.1M $26.2M $29.9M $38.2M $45.4M
Total Equity $7.6B $11.6B $10.6B $10B $10.8B
 
Total Liabilities and Equity $15B $24.4B $23B $21.3B $23.7B
Cash and Short Terms $458.7M $1.3B $1.7B $1.2B $1.3B
Total Debt $1.3B $3.2B $3.1B $3.1B $3.6B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $1.5B $2.1B $3.2B $4.3B $3.3B
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $17.5M $20.5M $25.5M $28.6M $38.8M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $1B $1.6B $1.9B $3.8B $2.4B
 
Capital Expenditures $193.7M $205.5M $236M $254.3M $344.8M
Cash Acquisitions $315M -$21.5M $259.5M -- -$99.5M
Cash From Investing $205.6M -$85.2M $66.8M -$136.9M -$294.7M
 
Dividends Paid (Ex Special Dividend) -$63.4M -$90.1M -$146.4M -$187.1M -$206.7M
Special Dividend Paid
Long-Term Debt Issued $366.6M $629.4M $2B $622.8M $30.8M
Long-Term Debt Repaid -$369.8M -$496.9M -$77.8M -$527.2M -$47.5M
Repurchase of Common Stock -$732.9M -$770.9M -$2.8B -$2.9B -$2B
Other Financing Activities -$1.8M -$766.1K $17.8M -$24.1M $10.6M
Cash From Financing -$1.1B -$1.1B -$1.4B -$3.4B -$2.6B
 
Beginning Cash (CF) $173.6M $313M $646M $1.2B $1.5B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $114.9M $416.9M $627.3M $231.8M -$456.8M
Ending Cash (CF) $306.3M $622.1M $1.3B $1.4B $936.7M
 
Levered Free Cash Flow $837.7M $1.4B $1.7B $3.6B $2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $642.3M $844.4M $925.1M $834.5M $894M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $6.1M $6.4M $6.6M $10.4M $12.6M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $475.7M $266.4M $873.1M $546.3M $689.1M
 
Capital Expenditures $59.6M $60.1M $64M $96.5M $107.6M
Cash Acquisitions -- $289.9M -- -$8.3M --
Cash From Investing -$37.2M $240.2M -$18.2M -$24.6M -$161.1M
 
Dividends Paid (Ex Special Dividend) -$5.5M $3.2M $10.3M $170.7K -$4.6M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -$144.6M $1.2B -$67.4M $5.1M $16.9M
Long-Term Debt Repaid -$21.9M -$33.3M $106.2M -$1.3M -$325.6M
Repurchase of Common Stock -$28.5M -$621.6M -$590.7M -$614.1M -$128.4M
Other Financing Activities $7.4M -$9.6M $11.3M $6.7M $2.4M
Cash From Financing -$291.5M $396.1M -$626.6M -$685.8M -$550.2M
 
Beginning Cash (CF) $288.1M $329.6M $1.6B $1.4B $1.3B
Foreign Exchange Rate Adjustment $2.7M $71.3M -$43.9M -$19.4M -$28.3M
Additions / Reductions $147M $902.6M $228.4M -$164.1M -$22.3M
Ending Cash (CF) $457M $1.3B $1.7B $1.3B $1.3B
 
Levered Free Cash Flow $416.1M $206.3M $809.2M $449.8M $581.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2B $2.7B $4.3B $3.6B $3.2B
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $20.4M $23.5M $26.8M $37.1M $46.4M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $1.4B $1.4B $3.6B $3.3B $1.6B
 
Capital Expenditures $213.4M $202.2M $220.6M $388.8M $351M
Cash Acquisitions $2M $237.1M $946.8K -$88.6M -$10.8M
Cash From Investing -$103.3M $138.6M -$125.1M -$312.9M -$283M
 
Dividends Paid (Ex Special Dividend) -$92.8M -$143.6M -$179.2M -$216.4M -$224.7M
Special Dividend Paid
Long-Term Debt Issued $650M $2.2B $718.8M $55.3M $668.5M
Long-Term Debt Repaid -$654.1M -$159.9M -$341.3M -$246.7M -$336.7M
Repurchase of Common Stock -$841.6M -$2.3B -$2.6B -$2.8B -$854.7M
Other Financing Activities $18.7M $37.5M -$35.7M $3.4M $10.9M
Cash From Financing -$1.3B -$751.4M -$2.9B -$3.5B -$1.2B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $15.8M $834.4M $572.5M -$502.1M $82M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.2B $1.2B $3.4B $2.9B $1.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.6B $2.2B $3.3B $2.6B $2.4B
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $15.7M $18.7M $20M $28.5M $36.1M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $1.1B $994.2M $2.6B $2.1B $1.3B
 
Capital Expenditures $156.2M $152.8M $137.4M $271.9M $278.1M
Cash Acquisitions -- $258.6M -- -$88.6M --
Cash From Investing -$98.8M $124.9M -$67M -$243M -$231.2M
 
Dividends Paid (Ex Special Dividend) -$92.4M -$145.9M -$178.7M -$208M -$225.9M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $376.2M $1.9B $585.1M $17.7M $655.4M
Long-Term Debt Repaid -$407.3M -$70.4M -$333.9M -$53.3M -$342.5M
Repurchase of Common Stock -$476M -$2B -$1.8B -$1.7B -$493.3M
Other Financing Activities $942.6K $39.2M -$14.4M $13.1M $13.4M
Cash From Financing -$847.4M -$526.4M -$2B -$2.1B -$723.7M
 
Beginning Cash (CF) $881.9M $1.7B $4.5B $4.6B $3.2B
Foreign Exchange Rate Adjustment -$39.3M $52.8M $83M -$32.6M -$35.1M
Additions / Reductions $175.3M $592.8M $538M -$195.8M $342.9M
Ending Cash (CF) $1B $2.3B $5B $4.4B $3.5B
 
Levered Free Cash Flow $965.3M $841.4M $2.5B $1.8B $1B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock